Overweight people taking newly approved diabetes drug lost an average of 49 pounds, study finds
Tirzepatide, which is sold under the brand name Mounjaro, has been studied in people without diabetes at three dosages: 5, 10, and 15 milligrams. Obese or overweight participants who took the 5 milligram dose lost an average of 35 pounds (16 kilograms), those who received the 10 milligram dose lost an average of 49 pounds …